Literature DB >> 21937674

Conversion of lipid transfer inhibitor protein (apolipoprotein F) to its active form depends on LDL composition.

Richard E Morton1, Diane J Greene2.   

Abstract

Lipid transfer inhibitor protein (LTIP) exists in both active and inactive forms. Incubation (37°C) of plasma causes LTIP to transfer from a 470 kDa inactive complex to LDL where it is active. Here, we investigate the mechanisms underlying this movement. Inhibiting LCAT or cholesteryl ester transfer protein (CETP) reduced incubation-induced LTIP translocation by 40-50%. Blocking both LCAT and CETP completely prevented LTIP movement. Under appropriate conditions, either factor alone could drive maximum LTIP transfer to LDL. These data suggest that chemical modification of LDL, the 470 kDa complex, or both facilitate LTIP movement. To test this, LDL and the 470 kDa fraction were separately premodified by CETP and/or LCAT activity. Modification of the 470 kDa fraction had no effect on subsequent LTIP movement to native LDL. Premodification of LDL, however, induced spontaneous LTIP movement from the native 470 kDa particle to LDL. This transfer depended on the extent of LDL modification and correlated negatively with changes in the LDL phospholipid + cholesterol-to-cholesteryl ester + triglyceride ratio. We conclude that LTIP translocation is dependent on LDL lipid composition, not on its release from the inactive complex. Compositional changes that reduce the surface-to-core lipid ratio of LDL promote LTIP binding and activation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21937674      PMCID: PMC3220293          DOI: 10.1194/jlr.M018283

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  38 in total

1.  Adsorption of apolipoprotein A-IV to phospholipid monolayers spread at the air/water interface. A model for its labile binding to high density lipoproteins.

Authors:  R B Weinberg; J A Ibdah; M C Phillips
Journal:  J Biol Chem       Date:  1992-05-05       Impact factor: 5.157

2.  Concentration of neutral lipids in the phospholipid surface of substrate particles determines lipid transfer protein activity.

Authors:  R E Morton; J V Steinbrunner
Journal:  J Lipid Res       Date:  1990-09       Impact factor: 5.922

3.  Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia.

Authors:  C J Mann; F T Yen; A M Grant; B E Bihain
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

Review 4.  Plasma lipid transfer proteins.

Authors:  A Tall
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

5.  Point mutagenesis of positively charged amino acids of cholesteryl ester transfer protein: conserved residues within the lipid transfer/lipopolysaccharide binding protein gene family essential for function.

Authors:  X C Jiang; C Bruce; T Cocke; S Wang; M Boguski; A R Tall
Journal:  Biochemistry       Date:  1995-05-30       Impact factor: 3.162

6.  Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma.

Authors:  T Murakami; S Michelagnoli; R Longhi; G Gianfranceschi; F Pazzucconi; L Calabresi; C R Sirtori; G Franceschini
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-11       Impact factor: 8.311

7.  Molecular packing of high-density and low-density lipoprotein surface lipids and apolipoprotein A-I binding.

Authors:  J A Ibdah; S Lund-Katz; M C Phillips
Journal:  Biochemistry       Date:  1989-02-07       Impact factor: 3.162

8.  Interaction of plasma-derived lipid transfer protein with macrophages in culture.

Authors:  R E Morton
Journal:  J Lipid Res       Date:  1988-10       Impact factor: 5.922

9.  Regulation of lipid transfer between lipoproteins by an endogenous plasma protein: selective inhibition among lipoprotein classes.

Authors:  R E Morton; D J Greene
Journal:  J Lipid Res       Date:  1994-05       Impact factor: 5.922

10.  Characterization of the core and surface of human plasma lipoproteins. A study based on the use of five fluorophores.

Authors:  V Ben-Yashar; Y Barenholz
Journal:  Chem Phys Lipids       Date:  1991-11       Impact factor: 3.329

View more
  5 in total

1.  Apolipoprotein F: a natural inhibitor of cholesteryl ester transfer protein and a key regulator of lipoprotein metabolism.

Authors:  Yan Liu; Richard E Morton
Journal:  Curr Opin Lipidol       Date:  2020-08       Impact factor: 4.776

2.  ApoF knockdown increases cholesteryl ester transfer to LDL and impairs cholesterol clearance in fat-fed hamsters.

Authors:  Richard E Morton; Yan Liu; Lahoucine Izem
Journal:  J Lipid Res       Date:  2019-09-11       Impact factor: 5.922

3.  Exon 9-deleted CETP inhibits full length-CETP synthesis and promotes cellular triglyceride storage.

Authors:  Lahoucine Izem; Yan Liu; Richard E Morton
Journal:  J Lipid Res       Date:  2020-01-27       Impact factor: 5.922

4.  Apolipoprotein F concentration, activity, and the properties of LDL controlling ApoF activation in hyperlipidemic plasma.

Authors:  Richard E Morton; Daniel Mihna
Journal:  J Lipid Res       Date:  2022-01-08       Impact factor: 5.922

5.  Decreased expression of ApoF associates with poor prognosis in human hepatocellular carcinoma.

Authors:  Ya-Bin Wang; Bo-Xuan Zhou; Yun-Biao Ling; Zhi-Yong Xiong; Rui-Xi Li; Yue-Si Zhong; Ming-Xing Xu; Yi Lu; Hao Liang; Gui-Hua Chen; Zhi-Cheng Yao; Mei-Hai Deng
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-04-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.